Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Zarate YA et al. – The authors recommend considering immunotherapy in addition to enzyme replacement therapy in those patients with confirmed Fabry disease and acute nephrotic syndrome with clinical and microscopic findings suggestive of minimal change disease.

   

Related Articles

Occupational health epidemiology in the Nordic countries - status and trends
Scandinavian Journal of Work, Environment & Health, 11/16/09    Relevance Score: 78%

Long-Lasting Measles Outbreak Affecting Several Unrelated Networks of Unvaccinated Persons
The Journal of Infectious Diseases, 10/29/09    Relevance Score: 78%

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09    Relevance Score: 78%

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial
Gut, 10/22/09    Relevance Score: 78%

Serum Immunoglobulin E Can Predict Minimal Change Disease Before Renal Biopsy
The American Journal of the Medical Sciences, 10/14/09    Relevance Score: 78%

Today in Glomerular/Tubular Dz...keeping you current

Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
American Journal of Kidney Diseases, 11/30/09

Risk of Incident ESRD: A Comprehensive Look at Cardiovascular Risk Factors and 17 Years of Follow-up in the Atherosclerosis Risk in Communities (ARIC) Study
American Journal of Kidney Diseases, 11/30/09

Renin-Angiotensin System Activation in Renal Adipogenesis
American Journal of Physiology: Renal Physiology, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address